MedTrace Logo

Rhinocort Aqua Versus Placebo and Fluticasone Propionate

NCT00641680 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 750

Last updated 2011-01-24

No results posted yet for this study

Summary

The purpose of this study is to compare once daily treatment with Rhinocort against placebo and Fluticasone Propionate at reliving the nasal symptoms of seasonal allergic rhinitis.

Conditions

  • Seasonal Allergic Rhinitis

Interventions

DRUG

Budesonide

DRUG

Fluticasone propionate

DRUG

Placebo

Sponsors & Collaborators

Principal Investigators

  • Michael E Ruff, MD · Pharmaceutical Research, Dallas, USA

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
12 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2003-04-30
Primary Completion
2003-07-31
Completion
2003-07-31

More Related Trials

Entities

Drugs
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00641680 on ClinicalTrials.gov